SLC35C1 and colonic neoplasm: And recently, Deng et al. found that SLC35C1 is a negative regulator of the classical Wnt pathway in colon cancer, and the deletion of SLC35C1 promotes colon cancer progression by activating the Wnt signaling pathway, a finding that further confirms our view5.